TY  - GEN
AU  - Engert,Andreas
AU  - Josting,Andreas
AU  - Haverkamp,Heinz
AU  - Villalobos,Matthias
AU  - Lohri,Andreas
AU  - Sökler,Martin
AU  - Zijlstra,Josée
AU  - Sturm,Isrid
AU  - Topp,Max S
AU  - Rank,Andreas
AU  - Zenz,Thorsten
AU  - Vogelhuber,Martin
AU  - Nogova,Lucia
AU  - Borchmann,Peter
AU  - Fuchs,Michael
AU  - Flechtner,Hans-Henning
AU  - Diehl,Volker
TI  - Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial
SN  - 1527-7755
PY  - 2010///0513
KW  - Adolescent
KW  - Adult
KW  - Anemia
KW  - blood
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bleomycin
KW  - Cyclophosphamide
KW  - Double-Blind Method
KW  - Doxorubicin
KW  - Epoetin Alfa
KW  - Erythrocyte Transfusion
KW  - Erythropoietin
KW  - adverse effects
KW  - Etoposide
KW  - Fatigue
KW  - drug therapy
KW  - Female
KW  - Germany
KW  - Hematinics
KW  - Hodgkin Disease
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Procarbazine
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2009.25.1835
ER  -